Biotech Values

[DewDiligence]

Thanks for your post on today’s NYT article about restricting access of cancer drugs (in this case, PLX4032) that have one or more pivotal trials in progress. #msg-46899517 has an earlier article in the same series, and #msg-53727349 has the PR reporting the PLX4032 phase-1 data. Regards, Dew

p.s. The clinicaltrials.gov entry for the phase-3 trial discussed in the NYT article is at http://clinicaltrials.gov/ct2/show/study/NCT01006980 .